Company Filing History:
5 out of 7 
1 out of 142 Years Active: 1998
Title: The Innovative Contributions of Ronald Ingram
Introduction
Ronald Ingram is a notable inventor based in Oceanside, CA, who has made significant contributions to the field of biomedical research. With a total of six patents to his name, Ingram's work focuses on the development of peptides that have the potential to alter bone resorption, angiogenesis, and restenosis. His innovative approaches aim to address critical health issues related to bone and vascular health.
Latest Patents
Ingram's latest patents include groundbreaking inventions such as "Peptides for altering bone resorption, angiogenesis and restenosis." This invention provides Arg-Gly-Asp peptides that can modify the binding of osteoclasts to a matrix, such as bone, and selectively alter integrin receptor binding. The methods outlined in this patent also focus on using these peptides to influence .alpha..sub.v .beta..sub.3 integrin receptor-mediated binding of various cells, including osteoclasts, endothelial cells, and smooth muscle cells, to a matrix. Furthermore, the invention offers methods for alleviating pathologies characterized by undesirable levels of bone resorption, angiogenesis, or restenosis in subjects.
Career Highlights
Throughout his career, Ronald Ingram has worked with esteemed organizations such as the La Jolla Cancer Research Center and the La Jolla Cancer Research Foundation. His experience in these institutions has allowed him to collaborate with leading researchers and contribute to significant advancements in cancer research and treatment.
Collaborations
Ingram has had the opportunity to work alongside talented individuals in his field, including Soan Cheng and Daniel G. Mullen. These collaborations have further enriched his research and innovation efforts.
Conclusion
Ronald Ingram's contributions to the field of biomedical research through his innovative patents and collaborations highlight his commitment to advancing health solutions. His work continues to pave the way for new treatments and understanding of critical health issues.